Fate Therapeutics
FATE
25 hedge funds and large institutions have $51.9M invested in Fate Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
9% more funds holding
Funds holding: 23 → 25 (+2)
0% more capital invested
Capital invested by funds: $51.7M → $51.9M (+$195K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.46M |
| 2 |
BC
Broadfin Capital
New York
|
+$349K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$182K |
| 4 |
Renaissance Technologies
New York
|
+$73.8K |
| 5 |
SIM
Spark Investment Management
New York
|
+$63.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$193K |
| 2 |
Goldman Sachs
New York
|
-$181K |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$153K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$79.4K |
| 5 |
Morgan Stanley
New York
|
-$20K |
FATE Hedge Fund Activity: Q1 2015 in Review
25 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Fate Therapeutics (FATE) for Q1 2015, worth a combined $51.9M — up 0.38% from $51.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FATE positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Highland Capital Management (Texas), adding an estimated $1.46M. The largest seller was DAFNA Capital Management, cutting an estimated $193K.
- 25 institutional investors held Fate Therapeutics (FATE) as of Q1 2015, up from 23 in Q4 2014.
- Funds reported $51.9M of Fate Therapeutics stock for Q1 2015, up 0.38% quarter-over-quarter.
- 4 funds opened new Fate Therapeutics positions in Q1 2015 and 2 closed out, a net change of +2 holders.
- The largest Fate Therapeutics buyer in Q1 2015 was Highland Capital Management (Texas), an estimated $1.46M added.
- The largest Fate Therapeutics seller in Q1 2015 was DAFNA Capital Management, an estimated $193K sold.
Based on aggregated 13F filings for Q1 2015.